Role of activator protein-1 in TCR-mediated regulation of the murine fasl promoter

被引:25
作者
Matsui, K
Xiao, S
Fine, A
Ju, ST
机构
[1] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA
[2] Boston Univ, Arthrit Ctr, Dept Med, Boston, MA 02118 USA
关键词
D O I
10.4049/jimmunol.164.6.3002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study demonstrates that transcription factor interactions are important in regulating the murine fasl promoter following TCR-mediated activation. We used DNase I-footprinting, EMSAs, and transient transfection assays to identify the minimal TCR signal-responsive region within the fasl promoter. This region contains the previously identified binding sites for NF-kappa B and Egr and the AP-1 site identified in this study. We found that TCR signaling induces AP-1 binding to this site and regulates the fasl promoter function in a fashion dependent on NF-kappa B binding, However, mutation in the AP-1 site alone did not show a significant effect on the promoter function. The data suggest that the minimal promoter required at least two transcription factors to function.
引用
收藏
页码:3002 / 3008
页数:7
相关论文
共 53 条
[1]   SPONTANEOUS MURINE LUPUS-LIKE SYNDROMES - CLINICAL AND IMMUNOPATHOLOGICAL MANIFESTATIONS IN SEVERAL STRAINS [J].
ANDREWS, BS ;
EISENBERG, RA ;
THEOFILOPOULOS, AN ;
IZUI, S ;
WILSON, CB ;
MCCONAHEY, PJ ;
MURPHY, ED ;
ROTHS, JB ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) :1198-1215
[2]   FAS-MEDIATED CYTOTOXICITY BY FRESHLY ISOLATED NATURAL-KILLER-CELLS [J].
ARASE, H ;
ARASE, N ;
SAITO, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1235-1238
[3]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[4]   A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN [J].
BOLDIN, MP ;
VARFOLOMEEV, EE ;
PANCER, Z ;
METT, IL ;
CAMONIS, JH ;
WALLACH, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :7795-7798
[5]   CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS [J].
BRUNNER, T ;
MOGIL, RJ ;
LAFACE, D ;
YOO, NJ ;
MAHBOUBI, A ;
ECHEVERRI, F ;
MARTIN, SJ ;
FORCE, WR ;
LYNCH, DH ;
WARE, CF ;
GREEN, DR .
NATURE, 1995, 373 (6513) :441-444
[6]   THE SEGMENT-SPECIFIC GENE KROX-20 ENCODES A TRANSCRIPTION FACTOR WITH BINDING-SITES IN THE PROMOTER REGION OF THE HOX-1.4 GENE [J].
CHAVRIER, P ;
VESQUE, C ;
GALLIOT, B ;
VIGNERON, M ;
DOLLE, P ;
DUBOULE, D ;
CHARNAY, P .
EMBO JOURNAL, 1990, 9 (04) :1209-1218
[7]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[8]   THE T-CELL RECEPTOR/CD3 COMPLEX - A DYNAMIC PROTEIN ENSEMBLE [J].
CLEVERS, H ;
ALARCON, B ;
WILEMAN, T ;
TERHORST, C .
ANNUAL REVIEW OF IMMUNOLOGY, 1988, 6 :629-662
[9]   Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription [J].
Cogswell, PC ;
Mayo, MW ;
Baldwin, AS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :491-497
[10]   Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation [J].
Cui, HL ;
ElKhatib, M ;
Sherr, DH ;
Ettinger, R ;
Sy, MS ;
MarshakRothstein, A ;
Ju, ST .
CELLULAR IMMUNOLOGY, 1996, 167 (02) :302-312